Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MADELINE REED

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1538851183
CMS profile
11507814
Location
FORDYCE, AR

General Payments · PY2023–2024

$375.67

  • Reported across 18 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$268.70

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $268.70 17

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $172.83 12
ITI, Inc. $34.89 1
Supernus Pharmaceuticals, Inc. $30.40 2
Neurocrine BioSciences, Inc. $16.63 1
Xeris Pharmaceuticals, Inc. $13.95 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $106.97 1
PY2024 $268.70 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $8.18 01/24/2024 Food and Beverage Undisputed 01/23/2026 1108069289 CMS
ABBVIE INC. $2.67 02/28/2024 Food and Beverage Undisputed 01/23/2026 1108069291 CMS
ABBVIE INC. $71.74 02/29/2024 Food and Beverage Undisputed 01/23/2026 1108069293 CMS
ABBVIE INC. $8.09 03/05/2024 Food and Beverage Undisputed 01/23/2026 1108069295 CMS
ABBVIE INC. $13.20 05/22/2024 Food and Beverage Undisputed 01/23/2026 1108069297 CMS
ABBVIE INC. $13.26 06/06/2024 Food and Beverage Undisputed 01/23/2026 1108069299 CMS
ABBVIE INC. $17.02 07/25/2024 Food and Beverage Undisputed 01/23/2026 1108069301 CMS
ABBVIE INC. $4.55 08/13/2024 Food and Beverage Undisputed 01/23/2026 1108069303 CMS
ABBVIE INC. $15.00 08/21/2024 Food and Beverage Undisputed 01/23/2026 1108069305 CMS
ABBVIE INC. $4.63 09/03/2024 Food and Beverage Undisputed 01/23/2026 1108069307 CMS
ABBVIE INC. $6.16 09/25/2024 Food and Beverage Undisputed 01/23/2026 1108069309 CMS
ABBVIE INC. $8.33 11/13/2024 Food and Beverage Undisputed 01/23/2026 1108069311 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $34.89 12/04/2024 Food and Beverage Undisputed 01/23/2026 1143587886 CMS
Neurocrine Biosciences, Inc. $16.63 09/18/2024 Food and Beverage Undisputed 01/23/2026 1150996740 CMS
Supernus Pharmaceuticals, Inc. $14.19 10/04/2024 Food and Beverage Undisputed 01/23/2026 1147885656 CMS
Supernus Pharmaceuticals, Inc. $16.21 11/01/2024 Food and Beverage Undisputed 01/23/2026 1147885658 CMS
Xeris Pharmaceuticals, Inc. $13.95 04/30/2024 Food and Beverage Undisputed 01/23/2026 1144633729 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.